CytomX Therapeutics
CTMX
CTMX
83 hedge funds and large institutions have $52.6M invested in CytomX Therapeutics in 2022 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 23 increasing their positions, 23 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
56% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 25
Holders
83
Holding in Top 10
–
Calls
$30K
Puts
–
Top Buyers
| 1 | +$3.55M | |
| 2 | +$1.54M | |
| 3 | +$1.18M | |
| 4 |
BI
BVF Inc
San Francisco,
California
|
+$1.15M |
| 5 |
Renaissance Technologies
New York
|
+$509K |
Top Sellers
| 1 | -$5.21M | |
| 2 | -$5.03M | |
| 3 | -$3.66M | |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$3.03M |
| 5 |
Millennium Management
New York
|
-$1.32M |